Yang Qiu
Director (MSAT),
ImmPACT Bio
Yang is currently the Director of MSAT at ImmPact Bio. He has held various leadership positions in process development and clinical manufacturing of various CAR-T or iPSC-derived cell therapy products (including VX-880 and VX-264 by Vertex Pharmaceutics, Ebvallo and ATA-188 by Atara Biotherapeutics, FT596, FT522 and FT819 by Fate Therapeutics).